.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Citi
QuintilesIMS
Dow
Teva
Moodys
Baxter
Chinese Patent Office
Daiichi Sankyo
Medtronic

Generated: July 28, 2017

DrugPatentWatch Database Preview

ALBENZA Drug Profile

« Back to Dashboard

What is the patent landscape for Albenza, and what generic Albenza alternatives are available?

Albenza is a drug marketed by Amedra Pharms Llc and Impax Labs Inc and is included in two NDAs.

The generic ingredient in ALBENZA is albendazole. There are nine drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the albendazole profile page.

Summary for Tradename: ALBENZA

Patents:0
Applicants:2
NDAs:2
Suppliers / Packagers: see list3
Bulk Api Vendors: see list90
Clinical Trials: see list1
Patent Applications: see list2,065
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ALBENZA at DailyMed

Pharmacology for Tradename: ALBENZA

Drug ClassAntihelminthic
Mechanism of ActionCytochrome P450 1A Inducers
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amedra Pharms Llc
ALBENZA
albendazole
TABLET, CHEWABLE;ORAL207844-001Jun 11, 2015DISCNNoNo► Subscribe► Subscribe► Subscribe
Impax Labs Inc
ALBENZA
albendazole
TABLET;ORAL020666-001Jun 11, 1996RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
Daiichi Sankyo
QuintilesIMS
US Department of Justice
Merck
Dow
US Army
AstraZeneca
Cerilliant
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot